HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Yamagami Selected Research

Vascular Access Devices (Arterial Line)

7/2010Embolisation of the right gastric artery in patients undergoing hepatic arterial infusion chemotherapy using two possible approach routes.
2/2009Evaluation of non-target arterial patency after implantation of hepatic arterial catheter using a modified implantation technique with the fixed catheter tip method.
6/2008Redistribution of multiple hepatic arteries into a single hepatic artery to perform repeated hepatic arterial infusion chemotherapy.
4/2007Embolization of accessory left gastric artery to prevent acute gastric mucosal lesions in patients undergoing repeated hepatic arterial infusion chemotherapy.
2/2007Percutaneous transluminal angioplasty using a pull-through technique for hepatic arterial occlusion at the time of port-catheter implantation.
10/2006A simplified method for continuous hepatic arterial port-catheter system placement not requiring catheter end-hole occlusion.
2/2006Percutaneous transluminal angioplasty for hepatic arterial occlusion following hepatic arterial infusion chemotherapy.
12/2005Movement of the side hole occurring in a port-catheter system percutaneously implanted for hepatic arterial infusion chemotherapy.
10/2002Brain infarction after percutaneous implantation of port-catheter system via the left subclavian artery.
2/2002Catheter-tip fixation of a percutaneously implanted port-catheter system to prevent dislocation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Yamagami Research Topics

Disease

9Neoplasms (Cancer)
01/2017 - 05/2000
7Liver Neoplasms (Liver Cancer)
07/2010 - 02/2002
3Venous Thrombosis (Deep-Vein Thrombosis)
05/2008 - 10/2003
2Portal Hypertension
04/2011 - 09/2000
2Pneumothorax
12/2009 - 10/2006
2Chylous Ascites
04/2009 - 09/2005
2Esophageal and Gastric Varices (Esophageal Varices)
10/2008 - 08/2007
2Arterial Occlusive Diseases (Arterial Occlusive Disease)
02/2007 - 02/2006
2False Aneurysm (Pseudoaneurysm)
02/2007 - 12/2006
1Odontogenic Tumors (Dental Tissue Neoplasm)
01/2017
1Joint Diseases (Joint Disease)
09/2009
1Foreign-Body Reaction
09/2009
1Chylothorax
04/2009
1T-Cell Leukemia (Leukemia, T Cell)
07/2007
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
07/2007
1Inflammation (Inflammations)
02/2007
1Wounds and Injuries (Trauma)
02/2007
1Abdominal Aortic Aneurysm
12/2006
1Thrombosis (Thrombus)
07/2006
1Cadmium Poisoning (Itai Itai)
06/2006
1Hepatocellular Carcinoma (Hepatoma)
12/2005
1Graft vs Host Disease (Graft-Versus-Host Disease)
04/2005
1Pathologic Complete Response
04/2005
1B-Cell Lymphoma (Lymphoma, B Cell)
04/2005
1Epidermal Nevus
02/2005
1Leukemia
02/2005
1Papilloma (Papillomatosis)
02/2005
1Hematologic Neoplasms (Hematological Malignancy)
02/2005
1Adenosquamous Carcinoma
06/2004
1Residual Neoplasm
06/2004
1Pathologic Constriction (Stenosis)
10/2003
1Pulmonary Embolism
10/2003
1Brain Infarction
10/2002
1Diabetes Mellitus
08/2001
1Thyroid Neoplasms (Thyroid Cancer)
03/2001
1Cysts
03/2001
1Sialorrhea
10/2000
1Parkinson Disease (Parkinson's Disease)
10/2000
1Dyskinesias (Dyskinesia)
10/2000
1Hemorrhage
09/2000
1Fistula
09/2000

Drug/Important Bio-Agent (IBA)

3EnbucrilateIBA
02/2007 - 09/2000
2AntibodiesIBA
01/2017 - 02/2005
2Glucose (Dextrose)FDA LinkGeneric
10/2008 - 08/2007
2ChromatinIBA
05/2006 - 09/2002
2Tryptases (Tryptase)IBA
05/2006 - 09/2002
1Amyloid (Amyloid Fibrils)IBA
01/2017
1AmelogeninIBA
01/2017
1SiliconesIBA
09/2009
1Triglycerides (Triacylglycerol)IBA
04/2009
1Iopamidol (Isovue)FDA LinkGeneric
10/2008
1Sclerosing Solutions (Sclerosing Agents)IBA
10/2008
1ethanolamine oleate (Ethamolin)FDA Link
10/2008
1SolutionsIBA
08/2007
1CadmiumIBA
06/2006
1Immunosuppressive Agents (Immunosuppressants)IBA
04/2005
1Immunoglobulin G (IgG)IBA
02/2005
1Viral DNAIBA
02/2005
1Immunoglobulin M (IgM)IBA
02/2005
1WT1 ProteinsIBA
02/2005
1degradable starch microspheresIBA
06/2004
1Hypoglycemic Agents (Hypoglycemics)IBA
08/2001
1alpha-Glucosidases (Acid Maltase)IBA
08/2001
1ProstaglandinsIBA
07/2001
1Iodine-131IBA
03/2001
1Levodopa (L Dopa)FDA LinkGeneric
10/2000
1Gadolinium DTPA (Magnevist)FDA Link
05/2000

Therapy/Procedure

10Vascular Access Devices (Arterial Line)
07/2010 - 02/2002
5Drug Therapy (Chemotherapy)
06/2008 - 10/2002
3Vena Cava Filters (Inferior Vena Cava Filter)
05/2008 - 10/2003
2Chest Tubes (Chest Tube)
12/2009 - 10/2006
2Conservative Treatment
04/2009 - 09/2005
2Therapeutics
05/2008 - 07/2006
2Catheters
10/2006 - 12/2005
1Transjugular Intrahepatic Portasystemic Shunt
04/2011
1Arthroplasty
09/2009
1Arthrodesis
09/2009
1Total Parenteral Nutrition
04/2009
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
07/2007
1Operative Surgical Procedures
02/2007
1Lymph Node Excision (Lymph Node Dissection)
09/2005
1Stem Cell Transplantation
04/2005
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
04/2005
1Immunotherapy
02/2005
1Glycemic Control
08/2001
1Pallidotomy
10/2000